Scott M Whitcup Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott M Whitcup.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott M Whitcup. Scott M Whitcup is an Executive Vice President, R&D in ALLERGAN INC ($AGN) and an Executive VP, R&D, CSO in ALLERGAN INC ($AGN) and a Director in Menlo Therapeutics Inc. ($MNLO) and a Director in Adverum Biotechnologies, Inc. ($ADVM) and a Director in Nightstar Therapeutics plc ($NITE).
Address: 2525 DUPONT DRIVE IRVINE 92612 CA
Companies in which Scott M Whitcup is an Insider
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Scott M Whitcup: Director
Holdings: 0 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALLERGAN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott M Whitcup: Executive VP, R&D, CSO, Executive Vice President, R&D
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2015
$AGN Market Capitalization: $90.46B
$AGN Previous Close: $232.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nightstar Therapeutics plc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Scott M Whitcup: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott M Whitcup: Director
Holdings: 0 shares
Latest Transaction: Jun 27 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Scott M Whitcup
Sentiment: All, ADVM, AGN, NITE, MNLO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Apr 20 2020 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 11.62 | 60,000 | 697,200 | 60,000 | |
| Jun 27 2019 | MNLO | Menlo Therapeutics ... | Whitcup Scott M | Director | Option Exercise | A | 6.02 | 22,500 | 135,450 | 134,099 | |
| Jun 07 2019 | NITE | Nightstar Therapeu ... | Whitcup Scott M | Director | Option Exercise | D | 13.57 | 21,000 | 284,970 | 0 | |
| Jun 07 2019 | NITE | Nightstar Therapeu ... | Whitcup Scott M | Director | Option Exercise | D | 12.27 | 18,200 | 223,314 | 0 | |
| Jun 07 2019 | NITE | Nightstar Therapeu ... | Whitcup Scott M | Director | Sell | D | 25.50 | 74,568 | 1,901,484 | 0 | 74.6 K to 0 (-100.00 %) |